Search for: "Quest Pharmaceuticals, Inc" Results 21 - 40 of 53
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Mar 2009, 8:00 am
(Intellectual Property Watch) Two final thoughts on big pharma acquisitions (IP finance) Brazil: Patent term cutbacks in Brazil and pharmaceutical pipelines – IP Think Tank podcast 23 March 2009 (IP Think Tank) Brazil: Patent term cutbacks - Lobbying, intellectual property and superior courts (IP Think Tank) Brazil: Patent term extension (PTE) under TRIPs revisited and reviewed by Superior Court of Justice (IP tango) Denmark: Harmonisation in Denmark: Patents covering… [read post]
12 Nov 2010, 6:43 pm by John Rizvi
Supreme Court on Monday agreed to consider Stanford University's quest to assert the patent rights of its medical researchers, setting up a legal showdown between the nation's federally funded academic research arms and one of the world's pharmaceutical giants. [read post]
9 Jan 2014, 1:37 pm
Ryder Truck Rental, Inc., ___ F. [read post]
24 May 2010, 11:18 am by @ErikJHeels
(Seekonk, MA) African Pharmaceutical Development And Manufacturing Initiative, Inc. [read post]
10 Oct 2008, 3:22 pm
As a result of litigating medical device and pharmaceutical cases Attorney Fulmer has observed that in the past, scientists and inventors discovered something new and then developed companies around the discovery to serve the consumer. [read post]
29 Aug 2012, 3:15 am by Lawrence B. Ebert
Ranbaxy Pharmaceuticals, Inc., 336 F.3d 1322, 1330 (Fed. [read post]
17 Oct 2013, 6:39 pm by Geoff Cockrell
For example, in May 2013, Quest Diagnostics Inc. acquired Concentra’s toxicology and clinical laboratory business. [read post]
14 Mar 2013, 4:00 am by Administrator
This in turn requires that the subjective or discretionary element of claims interpretation (e.g., the elusive quest for “the spirit of the invention”) be kept to the minimum, consistent with giving “the inventor protection for that which he has actually in good faith invented” (Western Electric Co. v. [read post]
8 Dec 2015, 2:22 pm by Ben Vernia
  Daiichi Sankyo Inc., a global pharmaceutical company with its U.S. headquarters in New Jersey, paid $39 million to resolve allegations of false claims against the United States and state Medicaid programs. [read post]